Eligibility
unresectable uveal melanoma, malignancy
ONCOLOGY, LIVER METASTASIS, DISEASE
We included adult patients with unresectable uveal melanoma who had an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 and a life expectancy ≥12 weeks. Patients were required to have measurable disease, a liver metastasis accessible for injection, and no more than 25% of the liver involved by malignancy. Patients with disease involving the brain or spinal cord were excluded. Patients could enroll in the first line setting or after prior treatments. See 